Vulvovaginal Candidiasis
📧 Sign up to get email alerts when something new happens for Vulvovaginal Candidiasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-02-11FDA Approved: MONISTAT 3 3 DAY — Supplemental Application (Insight Pharmaceuticals LLC)
The FDA approved a supplemental application for MONISTAT 3 3 DAY (miconazole nitrate) filed by Insight Pharmaceuticals LLC.
-
FDA approval · 2014-02-11FDA Approved: MONISTAT 3 COMBINATION PACK — Supplemental Application (Insight Pharmaceuticals LLC)
The FDA approved a supplemental application for MONISTAT 3 COMBINATION PACK containing miconazole nitrate, manufactured by Insight Pharmaceu…
-
FDA approval · 2014-02-11FDA Approved: MONISTAT 1 COMBINATION PACK — Supplemental Application (Insight Pharmaceuticals LLC)
FDA approved a supplemental application for MONISTAT 1 COMBINATION PACK containing miconazole nitrate, submitted by Insight Pharmaceuticals …
-
FDA approval · 2014-02-11FDA Approved: MONISTAT 3 COMBINATION PACK 3 OVULE INSERTS — Supplemental Application (Insight Pharmaceuticals LLC)
FDA approved a supplemental application for MONISTAT 3 Combination Pack 3 Ovule Inserts containing miconazole nitrate, submitted by Insight …
-
CLINICAL_TRIALS trial_result · 2013-10-09Clinical Trial Update: Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) Treatment [Phase 2]
A Phase 2 dose-finding trial evaluating arasertaconazole nitrate pessaries for vulvovaginal candidiasis has completed, with results posted i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-07-10FDA Approved: MONISTAT 7 7-DAY DISPOSABLE APPLICATORS — Supplemental Application (Insight Pharmaceuticals LLC)
FDA approved a supplemental application for MONISTAT 7 7-day disposable applicators containing miconazole nitrate.
-
FDA approval · 2013-07-10FDA Approved: MONISTAT 1 COMBINATION PACK — Supplemental Application (Insight Pharmaceuticals LLC)
The FDA approved a supplemental application for the Monistat 1 Combination Pack containing miconazole nitrate from Insight Pharmaceuticals L…
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis [Phase 2]
A Phase 2 trial evaluating whether adding MGCD290 to fluconazole improves outcomes versus fluconazole alone for moderate to severe vulvovagi…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal Candidiasis [NA]
Clinical trial comparing safety and equivalence of a terconazole vaginal suppository (test product) to the reference product for vulvovagina…
-
FDA approval · 2013-02-06FDA Approved: MONISTAT 3 COMBINATION PACK 3 OVULE INSERTS — Supplemental Application (Insight Pharmaceuticals LLC)
FDA approved a supplemental application for MONISTAT 3 Combination Pack (3 ovule inserts) containing miconazole nitrate.
-
FDA approval · 2013-01-29FDA Approved: MONISTAT 3 3 DAY — Supplemental Application (Insight Pharmaceuticals LLC)
FDA approved a supplemental application for MONISTAT 3 3 DAY (miconazole nitrate) by Insight Pharmaceuticals LLC.
-
FDA approval · 2013-01-29FDA Approved: MONISTAT 3 COMBINATION PACK — Supplemental Application (Insight Pharmaceuticals LLC)
The FDA approved a supplemental application for MONISTAT 3 Combination Pack containing miconazole nitrate from Insight Pharmaceuticals LLC. …
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formulations [NA]
A randomized study comparing two 2% butoconazole nitrate vaginal cream formulations to assess therapeutic equivalence in vulvovaginal candid…
-
FDA approval · 2013-01-16FDA Approved: TERCONAZOLE VAGINAL CREAM 0.8% — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
The FDA approved a supplemental application for Terconazole vaginal cream 0.8% from E. Fougera & Co. a division of Fougera Pharmaceuticals, …
-
CLINICAL_TRIALS trial_result · 2012-12-24Clinical Trial Update: Safety and Immunogenicity Study of a Virosomal Vaccine Against Recurrent Vulvovaginal Candida Infection [Phase 1]
A Phase 1 trial evaluating the safety and immunogenicity of a virosomal vaccine for recurrent vulvovaginal candidiasis. The study status is …
-
FDA approval · 2012-05-18FDA Approved: GYNAZOLE 1 — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved GYNAZOLE 1 as an original application for a generic butoconazole nitrate vaginal antifungal, manufactured by Padagis Israel Pha…
-
FDA approval · 2012-03-14FDA Approved: FLUCONAZOLE — Supplemental Application (Hospira, Inc)
The FDA approved a supplemental application for fluconazole submitted by Hospira, Inc., authorizing changes to the product under the ANDA.
-
FDA approval · 2012-01-30FDA Approved: FLUCONAZOLE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc.'s generic fluconazole under Original Application (ANDA 078698). The approval covers multiple fun…
-
CLINICAL_TRIALS trial_result · 2011-08-09Clinical Trial Update: Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina [Phase 4]
Phase 4 clinical trial evaluating whether exercise influences the distribution of miconazole nitrate vaginal ovules in vulvovaginal candidia…
-
FDA approval · 2011-03-07FDA Approved: FLUCONAZOLE — Original Application (ANI Pharmaceuticals, Inc.)
ANI Pharmaceuticals received FDA approval for an original generic application of fluconazole.
-
FDA approval · 2009-12-21FDA Approved: MONISTAT 3 COMBINATION PACK — Supplemental Application (Insight Pharmaceuticals LLC)
The FDA approved a supplemental application for MONISTAT 3 COMBINATION PACK containing miconazole nitrate from Insight Pharmaceuticals LLC.
-
FDA approval · 2009-11-05FDA Approved: MONISTAT 7 7-DAY DISPOSABLE APPLICATORS — Supplemental Application (Insight Pharmaceuticals LLC)
FDA approved a supplemental application to Monistat 7 to include 7-day disposable applicators, expanding the delivery method of the miconazo…
-
CLINICAL_TRIALS trial_result · 2009-05-08Clinical Trial Update: Monthly Itraconazole Versus Classic Homeopathy for Treatment of Recurrent Vulvovaginal Candidiasis (RVVC) [NA]
A completed clinical trial compared monthly itraconazole to classic homeopathy for recurrent vulvovaginal candidiasis, with results posted i…
-
FDA approval · 2008-08-21FDA Approved: MONISTAT 7 7-DAY DISPOSABLE APPLICATORS — Supplemental Application (Insight Pharmaceuticals LLC)
The FDA approved a supplemental application for MONISTAT 7 7-DAY DISPOSABLE APPLICATORS containing miconazole nitrate from Insight Pharmaceu…
-
CLINICAL_TRIALS trial_result · 2008-05-22Clinical Trial Update: Diabetes Mellitus and Vulvovaginal Candidiasis [Phase 3]
A Phase 3 clinical trial sponsored by the Indian Council of Medical Research evaluating a treatment for diabetes mellitus and vulvovaginal c…